Elixxer Ltd (ELIXF)

Elixxer Ltd. is a common stock listing on OTC Markets under the symbol ELIX.F. The company is based in Montreal, Canada, and the available description indicates that it does not have significant operations. Its stated business focus is on investing in the cultivation and production of cannabis products. As a common equity security, the listing represents ownership in the company rather than a fund, debt instrument, or other specialized security type.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-ELIX.F
$0.017
-50.6% Downside
Expensive
Fair
0.0%
September 1, 2026
-1.2x
-0.4x
3.191 M
9.871 M
68.9%
15.4%
-351.6
18.2%
Valuation • Fair Value

Elixxer Ltd (OTC-ELIX.F) Fair Value by Valuation Model

Compare the primary fair value estimate for Elixxer Ltd (OTC-ELIX.F) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.017

Estimated downside of 50.6% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.017

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Elixxer Ltd (OTC-ELIX.F) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Elixxer Ltd (OTC-ELIX.F)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Elixxer Ltd (OTC-ELIX.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Elixxer Ltd (OTC-ELIX.F)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

NM

Forensic accounting screen.

Altman Z-Score

-351.6

Lower score that deserves closer risk review.

FCF / Net Income

18.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Elixxer Ltd (OTC-ELIX.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Elixxer Ltd (OTC-ELIX.F)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 1, 2026

Days to Earnings

42

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Elixxer Ltd (OTC-ELIX.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Elixxer Ltd (OTC-ELIX.F) Stock Forecast & Technical Outlook

Review Elixxer Ltd (OTC-ELIX.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Not available

The 15-minute technical signal for Elixxer Ltd (OTC-ELIX.F) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Not available

The 1-hour technical signal for Elixxer Ltd (OTC-ELIX.F) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Elixxer Ltd (OTC-ELIX.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Elixxer Ltd (OTC-ELIX.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Elixxer Ltd (OTC-ELIX.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Elixxer Ltd (OTC-ELIX.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Elixxer Ltd (OTC-ELIX.F) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

Elixxer Ltd (OTC-ELIX.F) Stock FAQ

Quick answers about Elixxer Ltd (OTC-ELIX.F) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.017
Estimated downside 50.6%
Valuation Rating
Overvalued
Estimated downside of 50.6%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

The current fair value estimate for Elixxer Ltd (OTC-ELIX.F) is $0.017. This implies an estimated downside of 50.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 50.6% versus the current market price.

An analyst price target for Elixxer Ltd (OTC-ELIX.F) is not currently available in the latest data file.

The current financial health read for Elixxer Ltd (OTC-ELIX.F) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Elixxer Ltd (OTC-ELIX.F) is September 1, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Elixxer Ltd (OTC-ELIX.F) is -1.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Elixxer Ltd is 3.191 M.

The current enterprise value listed for Elixxer Ltd is 9.871 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Elixxer Ltd is OTC-ELIX.F, and the stock is listed on OTC Markets.

Elixxer Ltd (OTC-ELIX.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Elixxer Ltd is 68.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Elixxer Ltd is 15.4%. Free float helps investors understand how much of the share base is available for public trading.